Recombinant Human Collagen III
The rhCol III was derived from the fragment of human type III collagen, and the fourth strain, Pichia Pasteuris, was used in accordance with the Chinese Pharmacopoeia "Management and Quality Control of Bacterial Strains for the Production and Verification of Biological Products".
The product is a high molecular biological protein by preparation process that uses genetic engineering recombination technology. From molecular design, activity screening to strain construction, through high-density fermentation, separation, purification and other processes to produces a high safety and does not contain any pathogenic microorganisms.